RSM logo
Phlebology

Home Current issue Browse archive Alerts About the journal Feedback
 
Phlebology 2009;24:176-182
doi:10.1258/phleb.2009.008081
© 2009 Royal Society of Medicine Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Hamel-Desnos, C M
Right arrow Articles by Allaert, F A
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Articles

Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases

C M Hamel-Desnos * , J-L Gillet {dagger}, P R Desnos {ddagger} and F A Allaert §

* Saint Martin Private Hospital, Vascular Medicine, Caen; {dagger} Private Practice, Vascular Medicine, Bourgoin Jallieu; {ddagger} Private Surgery, Vascular Medicine, 2 avenue de Bagatelle, Caen, France; § Mc Gill University, Epidemiology, Biostatistics and Occupational Medicine, Montreal, Canada

Correspondence: C Hamel-Desnos MD, Saint Martin Private Hospital, 18 rue des Roquemonts, 14050 Caen, France Email: claudine{at}desnos.eu

Objectives: The aim of this study was to assess thrombotic complications following sclerotherapy in thrombophilic patients in combination with thromboprophylaxis, in two randomized arms using low molecular weight heparin (LMWH) or warfarin.

Patients and methods: This study received approval from the Ethics Committee. A total of 105 patients (81 females, 24 males) ranging in age from 20 to 82 years (mean 50) were selected: 75 with Factor V Leiden mutation, 18 with prothrombin 20210A mutation, 7 with high level of Factor VIII, 5 combinations of these. After randomization, 51 and 54 patients received warfarin and LMWH, respectively. A total of 199 sclerotherapy sessions were performed. Foam was used in 160 treatments.

Results: No episodes of symptomatic deep vein thrombosis (DVT) or pulmonary embolism (PE) occurred; no instances of DVT were revealed by ultrasound-monitoring.

Conclusions: This study suggests that in the three most common forms of thrombophilia, sclerotherapy, in combination with thromboprophylaxis, can be performed safely. Prophylaxis with LMWH is easier to use than warfarin.

Key Words: factor V Leiden mutation • thrombosis • prophylaxis • varicose veins • foam sclerotherapy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor